Ethical considerations for clinical trials in inflammatory bowel disease

Gastroenterology and Hepatology

Volumn 10, Issue 1, 2014, Pages 37-41

  Rubin, David T ^a   Becker, Samuel ^b   Siegler, Mark ^c  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

Clinical trials; Ethics; Inflammatory bowel disease; Surgical interventions

Indexed keywords

MONOCLONAL ANTIBODY; PLACEBO;

GASTROINTESTINAL SURGERY; HUMAN; INFLAMMATORY BOWEL DISEASE; REMISSION; RESEARCH ETHICS; REVIEW; TREATMENT OUTCOME; VULNERABLE POPULATION;

EID: 84893140110     PISSN: 15547914     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. WMA declaration of Helsinki - ethical principles for medical research involving human species. WMA. http://www.wma.net/en/30publications/10policies/ b3/. Accessed November 20, 2013.
2. The Belmont report ethical principles and guidelines for the protection of human subjects of research. The National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. http://videocast.nih.gov/ pdf/ohrp-belmont-report.pdf. Accessed November 20, 2013.
3. Code of federal regulations - title 45 part 46 protection of human subjects. US Department of Health and Human Services. http://www.hhs.gov/ohrp/ human-subjects/guidance/45cfr46.html. Accessed August 7, 2013.
4. Sachar DB. Placebo-controlled clinical trials in gastroenterology. A position paper of the American College of Gastroenterology. Am J Gastroenterol. 1984;79(12):913-917. (Pubitemid 15224041)
5. Sands BE. The placebo response rate in irritable bowel syndrome and inflammatory bowel disease. Dig Dis. 2009;27(suppl 1):68-75.
6. Coffey MJ, Wilfond B, Ross LF. Ethical assessment of clinical asthma trials including children subjects. Pediatrics. 2004;113(1 pt 1):87-94. (Pubitemid 38057499)
7. Psaty BM, Lumley T, Furberg CD, et al. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA. 2003;289(19):2534-2544. (Pubitemid 37430155)
8. Rubin DT. What you see is not always what you get: raising the bar on clinical trial methodology in ulcerative colitis. Gastroenterology. 2013;145(1):45-47.
9. Nguyen GC, Sam J, Murthy SK, Kaplan GG, Tinmouth JM, LaVeist TA. Hospitalizations for inflammatory bowel disease: profile of the uninsured in the United States. Inflamm Bowel Dis. 2009;15(5):726-733.
10. Hafner-Eaton C. Physician utilization disparities between the uninsured and insured. Comparisons of the chronically ill, acutely ill, and well nonelderly populations. JAMA. 1993;269(6):787-792. (Pubitemid 23039088)
11. Kappelman MD, Porter CQ, Galanko JA, et al. Utilization of healthcare resources by U.S. children and adults with inflammatory bowel disease. Inflamm Bowel Dis. 2011;17(1):62-68.
12. Franks P, Meldrum S, Fiscella K. Discharges against medical advice: are race/ethnicity predictors? J Gen Intern Med. 2006;21(9):955-960. (Pubitemid 44141765)
13. Moore FD. The desperate case: CARE (costs, applicability, research, ethics). JAMA. 1989;261(10):1483-1484. (Pubitemid 19070381)
14. ANPRM for revision to common rule. US Department of Health and Human Services. http://www.hhs.gov/ohrp/humansubjects/anprm2011page.html. Accessed November 20, 2013.
15. Hanauer SB, Wagner CL, Bala M, et al. Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn's disease. Clin Gastroenterol Hepatol. 2004;2(7):542-553. (Pubitemid 38834038)
16. Sandborn WJ. Preventing antibodies to infliximab in patients with Crohn's disease: optimize not immunize. Gastroenterology. 2003;124(4):1140-1145. (Pubitemid 36389813)
17. Hanauer SB. The ethics of phase I trials of biologic agents. Nat Clin Pract Gastroenterol Hepatol. 2008;5(10):533.
18. Farrell RJ, Alsahli M, Jeen YT, Falchuk KR, Peppercorn MA, Michetti P. Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn's disease: a randomized controlled trial. Gastroenterology. 2003;124(4):917-924. (Pubitemid 36389794)
19. ClinicalTrials.gov. http://www.clinicaltrials.gov. Accessed November 20, 2013.
20. Glickman SW, McHutchison JG, Peterson ED, et al. Ethical and scientific implications of the globalization of clinical research. N Engl J Med. 2009;360(8):816-823.
21. Hanauer SB. Outsourcing clinical trials. Nat Rev Gastroenterol Hepatol. 2009;6(4):191.
22. Petryna A. Clinical trials offshored: on private sector science and public health. Biosocieties. 2007;2:21-40.
23. Ballantyne AJ. How to do research fairly in an unjust world. Am J Bioeth. 2010;10(6):26-35.
24. Biffl WL, Spain DA, Reitsma AM, et al Society of University Surgeons Surgical Innovation Project. Responsible development and application of surgical innovations: a position statement of the Society of University Surgeons. J Am Coll Surg. 2008;206(3):1204-1209.